Trial Profile
Phase I Three-way Crossover Bioequivalence Study of Pediatric Formulations of Lamivudine/Zidovudine/Nevirapine Using Healthy Adult Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Lamivudine/zidovudine/nevirapine (Primary) ; Lamivudine; Nevirapine; Zidovudine
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Elim Pediatric Pharmaceuticals
- 14 Nov 2011 New trial record